dangers of glp 1 drugs GLP-1 medication side effects for diabetes and weight loss Long-Term Risks of GLP-1 Drugs:

Once-Weekly Efpeglenatide Dose-Range Effects on Glycemic Control and Body Weight in Patients With Type 2 Diabetes on Metformin or Drug Naive, Referenced to Liraglutide

Medicare is not allowed to cover weight-loss drugs under current law and Medicaid coverage varies by state

Declaration of interests R.E.K., B.B-G., C.L.B., T.G., K.G.M., K.R.H., W.F.J.H., D.H.I., S.L., T.K., S.B.P., A.S., A.V., and K.R

We are providing access to compounded GLP-1s, which means customers can access treatment without navigating the shortages that are currently limiting access to the medication

Researchers observed that while GLP-1s offer overall kidney protective benefits, SGLT2 inhibitors appear to be more effective at slowing the progression to end-stage kidney failure

some studies suggested improvements in liver fibrosis of any stage [4953]